Ligand Pharmaceuticals Incorporated (LGND)

Nasdaq · Healthcare · Biotechnology
$286.85-0.03%As of 2026-11-22 · USD
Last session low $283.01Last session high $291.33
52-week low $175.8952-week high $326.63
Market cap
$5.74B
Sector
Healthcare
P/E (TTM)
115.2x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)39.0In the neutral range (30 to 70)
MACD (12, 26, 9)-2.91Below its signal line (0.47); histogram -3.38
Bollinger %B (20, 2)-2%Below the lower band (287.72 to 328.20)
SMA 20307.96Price is 6.9% below
SMA 50302.35Price is 5.1% below
SMA 200260.81Price is 10.0% above
ATR (20)3.90% of priceAverage true range per day
52-week position74%In the upper part of the 175.89 to 326.63 range

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Insider filings, 90 daysNo purchases and 10 sales (about $7.4M).
Latest fiscal yearEnded 2025-12-31: revenue of $268.09M and an operating margin of 17.6%.

More in Biotechnology